Rey; Allan W.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Rey; Allan W..The latest application filed is for "crystalline form of remdesivir".

Company Profile

12.25.32

Rey; Allan W. - Brantford CA
Rey; Allan W. - Quebec CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Crystalline form of Remdesivir Grant 11,377,456 - Souza , et al. July 5, 2	2022-07-05
Crystalline Form of Remdesivir App 20220144866 - Souza; Fabio E. S. ; et al.	2022-05-12
Processes for the Preparation of Zuclomiphene Intermediates App 20220119331 - Patel; Dineshkumar ; et al.	2022-04-21
Crystalline forms of niraparib tosylate Grant 11,236,066 - Stirk , et al. February 1, 2	2022-02-01
Crystalline form of Valbenazine dibesylate Grant 11,220,500 - Raheem , et al. January 11, 2	2022-01-11
Salts of Zuclomiphene App 20210292272 - Souza; Fabio E. S. ; et al.	2021-09-23
Crystalline forms of Ponatinib hydrochloride Grant 11,072,620 - Souza , et al. July 27, 2	2021-07-27
Crystalline Forms of Zuclomiphene Citrate App 20210221767 - Souza; Fabio E. S. ; et al.	2021-07-22
Processes for the preparation of zuclomiphene and intermediates thereof Grant 11,046,638 - Karadeolian , et al. June 29, 2	2021-06-29
Processes for the Preparation of Zuclomiphene and Intermediates Thereof App 20210147337 - Karadeolian; Avedis ; et al.	2021-05-20
Crystalline Forms of Niraparib Tosylate App 20210017151 - Stirk; Alexander J. ; et al.	2021-01-21
Crystalline Form of Valbenazine Dibesylate App 20200207761 - Raheem; Mohammed Abdul ; et al.	2020-07-02
Crystalline form of Olaparib Grant 10,662,178 - Rey , et al.	2020-05-26
Crystalline forms of benzoquinoline inhibitors of vesicular monoamine transporter 2 Grant 10,632,107 - Souza , et al.	2020-04-28
Crystalline Forms of Ponatinib Hydrochloride App 20200095255 - Souza; Fabio E. S. ; et al.	2020-03-26
Processes for the Preparation of Dasotraline and Intermediates Thereof App 20190390235 - Souza; Fabio E. S. ; et al.	2019-12-26
Crystalline forms of Lesinurad Grant 10,513,500 - Gerster , et al. Dec	2019-12-24
Crystalline Forms of Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2 App 20190343815 - Souza; Fabio E.S. ; et al.	2019-11-14
Crystalline form of selexipag Grant 10,407,396 - Souza , et al. Sept	2019-09-10
Crystalline Forms of Lesinurad App 20190263760 - Gerster; Jenny L. ; et al.	2019-08-29
Crystalline Form of Olaparib App 20190233400 - Rey; Allan W. ; et al.	2019-08-01
Crystalline Form of Selexipag App 20190144397 - Souza; Fabio E. S. ; et al.	2019-05-16
Crystalline forms of ibrutinib Grant 10,183,024 - Souza , et al. Ja	2019-01-22
Crystalline Forms of Ibrutinib App 20180153895 - Souza; Fabio E. S. ; et al.	2018-06-07
Solid Forms of Mirabegron App 20170291882 - Rey; Allan W. ; et al.	2017-10-12
Forms of vilazodone and processes for the preparation thereof Grant 9,382,233 - Weeratunga , et al. July 5, 2	2016-07-05
Forms Of Vilazodone And Processes For The Preparation Thereof App 20150175583 - Gamini; Weeratunga ; et al.	2015-06-25
Polymorphic forms of Rifaximin Grant 8,883,795 - Kothakonda , et al. November 11, 2	2014-11-11
Preparation of acid addition salts of amine bases by solid phase--gas phase reactions Grant 8,471,011 - Rey , et al. June 25, 2	2013-06-25
Polymorphic Forms Of Rifaximin App 20130090348 - Kothakonda; Kiran Kumar ; et al.	2013-04-11
Atorvastatin calcium propylene glycol solvates Grant 8,188,300 - Murthy , et al. May 29, 2	2012-05-29
Amorphous ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihy- dro-2H-indol-2-one hydrochloride) and processes to produce the same Grant 7,939,662 - Zetina-Rocha , et al. May 10, 2	2011-05-10
Salt form and cocrystals of adefovir dipivoxil and processes for preparation thereof Grant 7,935,817 - Blazecka , et al. May 3, 2	2011-05-03
Atorvastatin Calcium Propylene Glycol Solvates App 20110065931 - Murthy; K.S. Keshava ; et al.	2011-03-17
Atorvastatin calcium propylene glycol solvates Grant 7,834,195 - Murthy , et al. November 16, 2	2010-11-16
Preparation of acid addition salts of ziprasidone and intermediates thereof by solid phase-gas phase reactions Grant 7,745,624 - Rey , et al. June 29, 2	2010-06-29
Ibandronate sodium propylene glycol solvate and processes for the preparation thereof Grant 7,696,183 - Stradiotto , et al. April 13, 2	2010-04-13
Salt Form And Cocrystals Of Adefovir Dipivoxil And Processes For Preparation Thereof App 20090247749 - Blazecka; Peter Garth ; et al.	2009-10-01
Amorphous ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihy- dro-2H-indol-2-one hydrochloride) and processes to produce the same App 20090030204 - Zetina-Rocha; Carlos ; et al.	2009-01-29
Atorvastatin calcium propylene glycol solvates App 20080177087 - Murthy; K.S. Keshava ; et al.	2008-07-24
Ibandronate sodium propylene glycol solvate and processes for the preparation thereof App 20080139508 - Stradiotto; David A. ; et al.	2008-06-12
Ibandronate sodium propylene glycol solvate and processes for the preparation thereof App 20080139845 - Stradiotto; David A. ; et al.	2008-06-12
Process for the preparation of zonisamide and the intermediates thereof Grant 7,375,233 - Weeratunga , et al. May 20, 2	2008-05-20
Process for the preparation of Zonisamide and the intermediates thereof App 20080033181 - Weeratunga; Gamini ; et al.	2008-02-07
Process for the Preparation of Ziprasidone (5-[2-[4-(1,2-Benziosothiazol-3-Y1)-1-Piperazinyl]Ethyl]-6-Chloro-1,3-Dih- ydro-2H-Indol-2- One App 20070265447 - Zetina-Rocha; Carlos ; et al.	2007-11-15
Process for the preparation of zonisamide and the intermediates thereof App 20070142644 - Weeratunga; Gamini ; et al.	2007-06-21
Preparation of 4-(4-fluorophenyl)-N-alkylnipecotinate esters, 4-(4-fluorophenyl)-N-arylnipecotinate esters and 4-(4-fluorophenyl)-N-aralkylnipecotinate esters Grant 7,138,523 - Rey , et al. November 21, 2	2006-11-21
Preparation of acid addition salts of amine bases by solid phase-gas phase reactions App 20060205944 - Rey; Allan W. ; et al.	2006-09-14
Preparation of acid addition salts of ziprasidone and intermediates thereof by solid phase-gas phase reactions App 20060205947 - Rey; Allan W. ; et al.	2006-09-14
Preparation of an anhydrate form of 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihyd- ro-2H-indol-2-one hydrochloride (ziprasidone hydrochloride) Grant 7,087,611 - Zetina-Rocha , et al. August 8, 2	2006-08-08
Preparation of an anhydrate form of 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-pi- perazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride (ziprasidone hydrochloride) App 20050277651 - Zetina-Rocha, Carlos ; et al.	2005-12-15
Amorphous ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-p- iperazinyl]ethyl]-6-chloro-1, 3-dihydro-2H-indol-2-one hydrochloride) and processes to produce the same App 20050256139 - Zetina-Rocha, Carlos ; et al.	2005-11-17
Preparation of 4-(4-fluorophenyl)-N-alkylnipecotinate esters, 4-(4-fluorophenyl)-N-arylnipecotinate esters and 4-(4-fluorophenyl)-N-ara- lkylnipecotinate esters App 20030220370 - Rey, Allan W. ; et al.	2003-11-27
N-substituted 2-azetidinones Grant 5,412,092 - Rey , et al. May 2, 1	1995-05-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.